GoodRx Care vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hers beats GoodRx Care overall, scoring 7.3/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $199/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.
A side-by-side look at GoodRx Care and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
GoodRx Care
#48 of 52GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.
Visit GoodRx CareHers
#34 of 52The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit Hers| Feature | GoodRx Care | Hers |
|---|---|---|
| Our Score | 6.2/10 | 7.3/10 |
| Starting Price | $119/mo | $199/mo |
| Medication Type | Brand | Both |
| Insurance Accepted | Yes | No |
| Best For | Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing, $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand |
| Ranking | #48 | #34 |
| Get started | Visit GoodRx Care | Visit Hers |
Pros & Cons Compared
GoodRx Care
Pros
- +2026 subscription rewrite, $119/mo standard membership with medication priced among the lowest on the market
- +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
- +Oral Wegovy pill available at $149-199/mo, one of the cheapest oral semaglutide routes
- +Insurance accepted, GoodRx's integration with savings cards can stack with coverage
Cons
- −Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms
- −Compounded GLP-1s are de-emphasized on current marketing, may no longer be available
- −Subscription model means ongoing monthly fee even in maintenance months
- −Follow-up clinical care is still basic compared to dedicated GLP-1 platforms
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Our Verdict
Hers edges out GoodRx Care with a score of 7.3/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Hers's $199/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing, $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither GoodRx Care nor Hers feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing GoodRx Care or Hers tend to look at next.
- GoodRx Care vs Found$129/mo
- GoodRx Care vs Oak Longevity$133/mo
- GoodRx Care vs Ro$149/mo
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.